<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Coagulation cascade: Anticoagulant effects</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Coagulation cascade: Anticoagulant effects</h1>
<div class="graphic"><div class="figure"><div class="ttl">Coagulation cascade: Anticoagulant effects</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAW0AAAFGBAMAAABTRNPkAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAJ1BMVEX///8AAAARERGIiIhVVVXR0dGvr68tLS3u7u53d3dERERlZWWampoOEBreAAAPGElEQVR42uzdzXPbxhUA8DVBgATFgx8AAhSoA2HXjtsTkIyTJumBOKT15ERqrHqSE9G0jpP2wHVrj9LpgdQ4cZJeSDepnaYHojPqh0/kdDI5pAfplP5Z3QfwSxZhhSQoAs3uQdbIFvnzcrH7sB8PhPDCCy+88MILL7zwwgsvvCSiZLXTPxOglQSaBM289SrADYDSib/wAOCzOW7v2vi7RnmTcDooKu1GabZu3TZ+lY25/95pJcPdaxVMEro9MOsn3LJGHCgJAHvQdGuCpbXZ5wPs0xmIoDwBqD4AlbhP9U24G/rBDhnXd6//jBsrvdciIrqdvltj9V0lJKfKRvuQ1Te1/a4LG3HnKsfVkVvwAVEQNvXAnTU+J+4H9cBtNdm/RPdj0DI72E4kqB9X3f5G2olg+LWRu3cfK/NEfYsW3NsFA9sJu3KhjO6ceVPr6KG77ZXxQ9hAEQGaIzftnnIT4ZFKXrWuB/V9FFyX1Y6ePVHfzC3DqaI8/dOdtcJ91oRDt18bnnKThzrJ06Zl01pvX+qjO6PmtKB969i+7Yj6Fm9/ST+or9HtVLC6sP++BbQ6/XngzoFhU/gtOdb8mkChi27JekETLylPBOxPLpPodpL/9QtH6Rxwi5eaKYX/oJ1O+Kf7KY3Nvk5phWc3072T7oq/n7+6GffFVV/gs5S6D1LqvsDd3M3d3M3d3J0Yd0ad91NZS6RbHM0xitA+0+12k+OWR1NFzD3/dxLqzikVktH8ex1QcqrAbr1xvq4HFbIFtNzQs5qssVv1gQBOhf1pO1Dq6Elwe6rC3FmD1XdOzWliH+frCKF2r+WN3DiZJ8AeHLldnOtLhnvYt44y24ISuL0SCeaPZAo1y564H4MmQNuy3S7O9SWjnVj2sD91l0kwX0cP3RvQHLtxMm/kxrm+RLglALj2bH1fC6fyxm6czBu5g7m+JLizJuu2Q3dz0r5tnMpz+045mMbT8GvgHrZwri8R7ftAJVkD3cTB/sTC/uQy+YVCa5+CWy3Cm8yNk3mB+xa8wjqcZFyXzymxzUqfq9tjfTiPq7ibu7mbu7mbu7mbu7mbu7mbu7mbu7mbu7mbu7+X7ji32q7L7dZEaP6fuNPQTgL3FqjE+ptRxzVA96neqzkqDFLg9m1qWwNcCqG2C+guNXYS7gaA29Ae9i3bK+EaoNsnzF3OqMmv79vM3kI3PXRr7KJMj7uOi5nhGmCK3E1aEwaW7deCNcAUuWVQjiyqBWuAKXFPimWnc5xPq5vHgxtyO6fPFwpKAvsTIkGL0LJXkuAIR/dkuesXSD3SzcjlzI4Ag+PSXPfSRX5S/mK1V9jtPYp2VwpQLrAvLTyNGsSCL8KNjGndkwAOBaX3ZwX3hpG3YdH9hKKilFZz58CIbid3PVoWzMylks86Q4wFBTOrZSpb7FdkUwBA9x7811o8UHdhxXuQIuxEux3qlCXFe7qDMhwrM3pRyagS1F8DhTVuScG9M9fh3wu/rRd1UzJ7oLr3vM/Rqka7dw2vTCz6E0MhobvDIsQD5n7LeGfqZqH59qLuTOQVPXOgWoR69Cv0utHuP+JuNp81BXPkxnOdGbWo5LaFGbf4l4X7FSHyfzpzoJq5c6BEjNederS7TZjbMQhVR27ZaL+fUQtaQduacRPBWNQtRl6WMweqg/o+iNi6JUXe7/w0dHsVMtRHbvIKbGcMqInUmLpfBnhj8f43sqOYHqhmbrEHMQWgJK5INqoFTQ9UM/eBlkmJe+ZANXN75TW/XXxleqAa3aXdtLinB6p7uHf4biLc8vm+3al9pNklTzgE0eeuQY7XlfyB9YO1dbmL8ONV7v5yAK9DM2dGjTvPq+/Von3/R+YkuwgRuwtfAVVCW739SPfb8AdivWnUixbVccDFCBYPNmRN/z0tiGCtrlP1+7v6gu4DuELG2UUkdxm3Z7IanxcDMHfeukObVs1teVewvg/0MILNqVkAdO/BEbofqtRe0C2zNhhmFyGfWEp7Cbcc7DCeEwOw9v2SQYY1lA37HR0H3CCCfQxa1iRyuPsb/1YCc9F28hD0UXYRCRYs3dCdhxKZGwOw+pYNFpyhjHY7Og646L5l3tTYRTnjJm74v/5u7xu2738Y7VF2kSXrW2C3O3NjAOYWxvXtDzo6DrgYweLBhpNuCYxF+xPl5zAYZxdZsn1XwJ4bA0zaN5M5+56OAy5GsHiwYerGN3+4Q7sL9t8qizAn2UWW608G/pW5McCkP2HuLfB1HHAxgsWDDVP3LXPIPg1v0f5k1VtieN1o75rfOQaIITTbyOxYWt28nE/B8TAh+erOvl3yoTvrnpuvTrRaxSVXlb9Yk9u7Mp1cQPf8fHXH6sGS1yqsr21Q2/q6TOEyfj/KV0cofDWbr66g+H2c40yMO88+/l7fgjIbNZtBfVcxEpSU+kuz+eryllLHOc7EuHGqiAVVNnkLwB65WSRYqDyTr67H7nteAyVp9W3nLVx0tcf56nLbJ/PV5Sk0ZeMdJWnt25YwCgndGAnO1je6CybdxznO5LiD/gTde2M3RoJB+57JV3d8xavgHGdy3EH/zdq3Y4zdGAmSu/DVTL460bK34FfUSJB73YW7uXvz7nDWivUgJFjPiXF3xLm7l00csoF20gjue0ejSyrcvZr7OzhqVOg/JVbfw21CWVRofwuHIjxqfbvKktHa3S2n1FBzFXTvYWjodiXjI+VDgPuLTzSdq9srNfSChm5CB+hmQQq9Dk1B+Wui3Y0Spg4J3G4N3SwopJ9DncWCekrc1J7Wd51Ij810uFn8Su1hi7Vv40Ncgi5sp8MN91mN3xr1J3UZoLuS29PJQVoWJ2fduQo5vpZCt2wQvz9ZnkqPW4Q7mLM8XJ5KUzxI/6OMl6dS5XZ+P01+nyZ3gw1c4+T3aXIXoDVJfp8mtwADcjL5Pb+/5G7u5m7u5m7u5m7u5m7u5m7u5m7u5m7u5m7u5u6Elo8C917q3Lk3mPtmNXVuGZ7AJ6usIi5WYlsZyIMCVtRDclYr8/JuxbeiMQSI75EKZ7rjK/hUdH19bnzkN+YLw8VR54fbXjWufGEZzDC1Pjc+8jvMF9brO4DumPKFCcxtr8fNXrmJj/zGvFu4OIqHq6px5VPKs1dvr62+7+Ajv9GNi6OxutmFuZ7LMmwnuHxu2cdVXByN192A0hrd+MhvPDyHi6PxunPrOlYT9icUupgvDBdH43UX4WjNg+R68m7lL7VT6SbfpDT+TkUQ29/kmzdOBxTPTcAzUy6OA7PyvFYYZ3rX4HwxXCOuPskXtpobD5xvn5dbzVv6JF9YY/kALqjvXiuivmPuv5nbEECf5AvD3dSYLyxr0KssvrgvwqN92IOvzfaDsw56TdwsnMxU6Mcu2FnTvfriNrF+ZtTDzdpxuum7VJ/kC8Pd1JgvLGsUlTaRFBEA3TYdnHkOfeJm4SQLYR+qhe2sgYkamhhthpu143Q71NEn+cJwNzXmC8tqeTj6JeC75vGLX7P+hYPIhegkBdN2gskDiFfCV5HgY+bGqC3YrB2n+12FNepxvjDcJYv5wh4w98twnZHrgdutOWdliHjWXZbYq4zcjVK4CTdO92+0jj7JF4ZuzBeW1UR4zxBn3OTLM27pnlffx9X43U1M2DLOFxY8+NJov5/VBEMwirNu6YwjA8+4c2pBnbj9WrxuTGkUuMf5wtCN+cKyhnVIfGPqvgHw94XaSd5V7LHb0kis7uiyRGqfi0kINpZw9wkv39fSCa4k2fhfe+fv2zQQxfFTUjchXfrsOI4ThlhVxQ91sBcEYnEW5mQAoU4JS1Ene+jCFIOQECw1A3MydKdiYE2Y+LO4986BNg2hJTnXJ913OmX65OWd7/wu931reLHKqZ840yu7v9G/uPvNW+cOr7jILOe+vEcvAHfFJa+tdvx+4tDVugRMA4fuvQScAXJXJ46DF2TS0yM4yzwYbp/bIq8tvn1r9OlqHY83DdE/adhB7kr7DnIDfHHeOZkHwzUFu9LyZF94bbEgqli4GeTcYsi2u2An9CpB3CaruQYct2+SJ9K4odUTXlss5W9YuMhzbhrabGj1iXvYzLgrfJ945BaCO0Sskoi32JxQvMlDMo0ybnsebx7rWrsw3OS1hZfIvgnuAQ1t/k1mxM03doKb5/bhC+HBUABu8tqymNGFE9oMBiYNbVaDmLiN+KHgZsfQGgkPhlvmli3Nrbk19//r6ukrvu/8LgyKI+SSix89xw+vW+yTy91v3pz7j0NX8bgXVHLFT0NfpgDcVYB9LFwGD9wy1EfBHjyKx1vO5KAqCpq4L6RaZX1ygh99bo3SZwAhGUV+b67qjyA/3n78NQA3HQdRsD+0KhbWNT+IgiZxY62yvuUg9zQ+TXmeCGNOaK7qj5BDnkxCnsXetG+jh1XFxbrmT1HQZNnRYMktm8jdSyPkFkaovrGqP0IO3HyqdaowSBpzbuY9zgpsi9xBB7mF8azPVvVHyIn7Urzx5H459/n4QrzZqv4Ikrkbc26e3+M5d9mpLud+GftpOLsv8ttnq/ojyOUu8+eJ4C5De5Rxm3D2F26PvxyFtex54m+v6o+g13nNrbnXU0p7vKSxyUMBWdwX/WOXcq/pvyWL+6J/7Jz78gt/MbnJXxN7o0KbuLGnQGKX2vHoHPwyOE/W/AOgJG7hZ0oesbgGYvwT5Ab4yLeElboxLma8hX9sd8ywRSpyY08Bzo2HvTstPJUuJncW75Bhi1Tkxp4CghsAu2UVO7/DKm5DkBt7CghuqmcW+3nC440tUpEbewoQd6XOnmJ+n0eF5KbnN+fGFqnIjT0FiJulcFD2HPQN0+u85tbcmvtmC+di8UbXNfPnXpCua24w3rqumTO3rmvmxy2lrvk6464OZHHLqWv+GAjuVz5TSkmrh9yHkq7WSdMO/+1g95Osq3XSxBNoDywPGopxM0/8DT9SjXsmuKeqcb8lbHOkGvcOcas2LaknNJetHDeLlZyW2cScqseN9/5N9bCxATe4CnIbak5LxiYAYxW5Z0pOS5yYKk5LfCGxlOQ21JyWG74MnaOGAzW5a0xLS0trbXl+9vBWqBNMANBRkruj5mKJ3LHffWNON+r3lhd3NLu/Ub+3PPIbewyGyd3N+mHlFO+wZKnJ3W+oyR1ESnJ7rZ5a3FpaWlpaWlpaWlpaWrejXzg3S0ASVrFjAAAAAElFTkSuQmCC"/></div><div class="graphic_lgnd">LMW heparins include enoxaparin, dalteparin, and tinzaparin. Unfractionated heparin and LMW heparin inhibit both factor Xa and thrombin; the effect of LMW heparins on thrombin is less than that of unfractionated heparin. Fondaparinux is a synthetic pentasaccharide based on the minimal antithrombin-binding region of heparin that inhibits factor Xa. LMW heparins, unfractionated heparin, and fondaparinux inhibit clotting factors by binding to antithrombin.<br/>Oral direct factor Xa inhibitors include apixaban, rivaroxaban, and edoxaban. Parenteral direct thrombin inhibitors include argatroban and lepirudin. Oral direct thrombin inhibitors include dabigatran.<br/>Coagulation factors are shown as Roman numerals. Only the activated forms (with the suffix "a") are shown for simplicity. Thrombin is also known as factor IIa.</div><div class="graphic_footnotes">LMW: low molecular weight.</div><div id="graphicVersion">Graphic 94856 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
